Exane Derivatives’s VEREIT, Inc. VER Stock Holding History

Exane Derivatives’s Portfolio VER Stock Details VER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6	Closed	-$271	–	1125
2021 Q3	$271	Hold	6	–	–	﹤0.01%	995
2021 Q2	$285	Sell	6 -3,278	-100%	-$148K	﹤0.01%	999
2021 Q1	$127K	Buy	3,284 +152	+5%	+$5.69K	0.04%	381
2020 Q4	$118K	Buy	+3,132	New	+$111K	0.03%	378
2017 Q4	–	Sell	-1	Closed	-$50	–	647
2017 Q3	$50	Sell	1 -22	-96%	-$928	﹤0.01%	536
2017 Q2	$936	Buy	23 +12	+109%	+$496	﹤0.01%	479
2017 Q1	$450	Hold	11	–	–	﹤0.01%	432
2016 Q4	$448	Sell	11 -15,049	-100%	-$666K	﹤0.01%	490
2016 Q3	$781K	Buy	+15,060	New	+$784K	0.12%	110
2016 Q2	–	Sell	-1,062	Closed	-$47.1K	–	639
2016 Q1	$47.1K	Buy	+1,062	New	+$42.2K	0.01%	323

Other funds holding VER

ING Group Amsterdam, Netherlands $20.5B AUM 49.71% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Kalos Management Alpharetta, Georgia $46.6M AUM 11.52% 1-Year Est. Return

Exane Derivatives's VER Position: Q4 2021 in Review

Exane Derivatives sold out of VEREIT, Inc. (VER) in Q4 2021, closing a stake of 6 shares — an estimated $271 sold.

Exane Derivatives first reported a position in VER in Q1 2016 and held it in 10 quarters. The position peaked at $781K in Q3 2016. 3 funds tracked by Wall St. Rank hold VER as of Q4 2021.

Exane Derivatives reported no remaining VEREIT, Inc. position as of Q4 2021 after selling out during the quarter.
Exane Derivatives sold 6 VEREIT, Inc. shares in Q4 2021, an estimated $271.
Exane Derivatives first reported a position in VEREIT, Inc. in Q1 2016 and held it in 10 quarters.
Exane Derivatives's VEREIT, Inc. position peaked at $781K in Q3 2016.
3 funds tracked by Wall St. Rank held VEREIT, Inc. as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.